Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.
作者信息
Aroor Annayya R, Whaley-Connell Adam, Sowers James R
机构信息
Diabetes and Cardiovascular Center, University of Missouri-Columbia School of Medicine, Columbia, MO, USA.
Department of Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO, USA.
出版信息
J Clin Hypertens (Greenwich). 2020 Feb;22(2):231-233. doi: 10.1111/jch.13817. Epub 2020 Jan 31.
Abstract
摘要
相似文献
1
Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.
J Clin Hypertens (Greenwich). 2020 Feb;22(2):231-233. doi: 10.1111/jch.13817. Epub 2020 Jan 31.
2
Prognostic significance of the renal resistive index in the primary prevention of type II diabetes.
J Clin Hypertens (Greenwich). 2020 Feb;22(2):223-230. doi: 10.1111/jch.13819. Epub 2020 Jan 31.
3
Renal resistive index: Beyond the hemodynamics.
J Clin Hypertens (Greenwich). 2020 Jul;22(7):1288-1289. doi: 10.1111/jch.13920. Epub 2020 Jul 9.
4
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes.
Diabetologia. 2011 Sep;54(9):2430-9. doi: 10.1007/s00125-011-2148-y. Epub 2011 Apr 16.
5
Increased renal resistive index in type 2 diabetes: Clinical relevance, mechanisms and future directions.
Diabetes Metab Syndr. 2017 Oct-Dec;11(4):291-296. doi: 10.1016/j.dsx.2016.08.019. Epub 2016 Aug 30.
6
Renal resistive index--a valid tool to assess renal endothelial function in humans?
Nephrol Dial Transplant. 2010 Jun;25(6):1869-74. doi: 10.1093/ndt/gfp754. Epub 2010 Feb 8.
7
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study.
Cardiovasc Diabetol. 2017 Oct 23;16(1):138. doi: 10.1186/s12933-017-0621-8.
8
Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S92-8. doi: 10.1097/01.asn.0000070142.14843.8e.
9
[Intrarenal resistive index (RI) from renal duplex Doppler sonography in type II diabetic patients with nephropathy].
Nihon Rinsho. 2002 Aug;60 Suppl 8:676-81.
10
Hypertension is Common in Patients with Newly Diagnosed Acromegaly and is Independently Associated with Renal Resistive Index.
High Blood Press Cardiovasc Prev. 2019 Feb;26(1):69-75. doi: 10.1007/s40292-018-0293-9. Epub 2018 Dec 7.
引用本文的文献
1
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.
Biomed Res Int. 2020 Oct 8;2020:2314128. doi: 10.1155/2020/2314128. eCollection 2020.
本文引用的文献
1
Measuring the Interaction Between the Macro- and Micro-Vasculature.
Front Cardiovasc Med. 2019 Nov 22;6:169. doi: 10.3389/fcvm.2019.00169. eCollection 2019.
2
Inflammatory proteins in diabetic kidney disease-potential as biomarkers and therapeutic targets.
Ann Transl Med. 2019 Sep;7(Suppl 6):S243. doi: 10.21037/atm.2019.08.20.
3
Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function.
Diabetes Care. 2019 Nov;42(11):2151-2153. doi: 10.2337/dc19-0528. Epub 2019 Sep 5.
4
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
Cardiovasc Diabetol. 2019 Mar 25;18(1):40. doi: 10.1186/s12933-019-0847-8.
5
Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review.
Int J Hypertens. 2019 Feb 17;2019:9189362. doi: 10.1155/2019/9189362. eCollection 2019.
6
Diet-Induced Obesity Promotes Kidney Endothelial Stiffening and Fibrosis Dependent on the Endothelial Mineralocorticoid Receptor.
Hypertension. 2019 Apr;73(4):849-858. doi: 10.1161/HYPERTENSIONAHA.118.12198.
7
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Cardiovasc Diabetol. 2018 Jul 30;17(1):108. doi: 10.1186/s12933-018-0750-8.
8
Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity?
Cardiorenal Med. 2017 Dec;8(1):41-49. doi: 10.1159/000479801. Epub 2017 Sep 30.
9
Clinical relevance of aortic stiffness in end-stage renal disease and diabetes: implication for hypertension management.
J Hypertens. 2018 Jun;36(6):1237-1246. doi: 10.1097/HJH.0000000000001665.
10
Renal Resistive Index as a Novel Indicator for Renal Complications in High-Fat Diet-Fed Mice.
Kidney Blood Press Res. 2017;42(6):1128-1140. doi: 10.1159/000485781. Epub 2017 Dec 7.
Zotero 插件